Litigation Details for MSP RECOVERY CLAIMS, SERIES LLC v. PFIZER INC. (D.N.J. 2018)
✉ Email this page to a colleague
MSP RECOVERY CLAIMS, SERIES LLC v. PFIZER INC. (D.N.J. 2018)
| Docket | ⤷ Try a Trial | Date Filed | 2018-09-28 |
| Court | District Court, D. New Jersey | Date Terminated | 2019-05-10 |
| Cause | 15:1 Antitrust Litigation | Assigned To | Peter G. Sheridan |
| Jury Demand | None | Referred To | Douglas Arpert |
| Patents | 6,126,971 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in MSP RECOVERY CLAIMS, SERIES LLC v. PFIZER INC.
The small molecule drugs covered by the patent cited in this case are ⤷ Try a Trial and ⤷ Try a Trial .
Details for MSP RECOVERY CLAIMS, SERIES LLC v. PFIZER INC. (D.N.J. 2018)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2018-09-13 | 1 | Complaint | the following patents in the Orange Book as covering Lipitor: 6,126,971 (the “’971 Patent”); 5,686,104… October of 2000 procured U.S. Patent No. 6,126,971 (the “’971 Patent,” expiry November 11, 2014). Both…follow-on patent (U.S. Patent Number 5,273,995, the “’995 Enantiomer Patent” or the “’995 Patent” or the… and patent applicant of both the ’893 Patent and the duplicative follow-on patent. Both patents issued…Stabilization Formulation Patents, the ’156 Patent, the ’995 Patent, and ’667 Patent), baseless sham litigation | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
